Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corneal temperature in schizophrenia patients.

Roni Shiloh1, Hanan Munitz, Shirley Portuguese

  • 1Geha Mental Health Center, Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petach-Tikva, Sackler Faculty of Medicine, Tel Aviv University, Israel.

The International Journal of Neuropsychopharmacology
|June 2, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

18-kDa Translocator Protein Ligands Protect H9C2 Cardiomyocytes from Cigarette Smoke-induced Cell Death: <i>In Vitro</i> Study.

In vivo (Athens, Greece)·2020
Same author

Levels of Proneness to Boredom in Children with Attention-Deficit/Hyperactivity Disorder On and Off Methylphenidate Treatment.

Journal of child and adolescent psychopharmacology·2020
Same author

Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.

Molecular psychiatry·2020
Same author

Poor performance of the 'child Reading the Mind in the Eyes Test' correlates with poorer social-emotional functioning in children with attention-deficit/hyperactivity disorder.

International clinical psychopharmacology·2020
Same author

The Placebo Response in Adult ADHD as Objectively Assessed by the TOVA Continuous Performance Test.

Journal of attention disorders·2020
Same author

Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia.

PloS one·2020

Schizophrenia patients, particularly those not on medication, show higher corneal temperatures. Antipsychotic drugs may normalize or lower this temperature, suggesting a link between dopamine, temperature regulation, and schizophrenia.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Thermoregulation

Background:

  • Dopaminergic transmission is crucial for core body temperature regulation.
  • Schizophrenia is linked to altered central dopaminergic pathways.
  • Schizophrenia patients may have thermoregulatory dysregulation, potentially affecting corneal temperature.

Purpose of the Study:

  • To investigate corneal temperature differences in drug-free and medicated schizophrenia patients compared to healthy controls.
  • To explore the relationship between antipsychotic drug treatment and corneal temperature in schizophrenia.

Main Methods:

  • Corneal temperature was measured using a FLIR thermal imaging camera.
  • A controlled sample included drug-free schizophrenia patients (n=11), medicated schizophrenia patients (n=28), and healthy subjects (n=9).

Related Experiment Videos

  • Medicated patients were further categorized into typical (n=16) and atypical (n=12) antipsychotic drug groups.

    • Main Results:

    • Drug-free schizophrenia patients exhibited significantly higher corneal temperatures (37.08°C) than healthy subjects (33.37°C) and both typical (31.08°C) and atypical (31.67°C) antipsychotic drug-treated patients.
    • Healthy subjects and atypical antipsychotic drug-treated patients had comparable corneal temperatures.
    • Typical antipsychotic drug-treated patients showed the lowest corneal temperatures.

    Conclusions:

    • Drug-free schizophrenia patients display elevated corneal temperatures.
    • Antipsychotic drugs appear to reduce corneal temperature, with atypical agents normalizing it and typical agents potentially lowering it below normal levels.
    • Further research with larger samples is needed to understand the clinical implications for schizophrenia pathophysiology and treatment monitoring.